by Neoteryx, on April 22,2021
At the end of March 2021, Quanterix Corporation issued a press release announcing that its Simoa® technology had been used in a research study to detect the SARS-CoV-2 virus. According …Read Story
by Neoteryx, on September 23,2020
LOS ANGELES and Cambridge, UK — September 2020 — The first commercially available SARS-CoV-2 antibody test in the UK compatible with Neoteryx’s Mitra® Microsampling device for at-home blood collection has …Read Story
by Neoteryx, on April 29,2020
“COVID-19 testing is top-of-mind for every researcher around the world at present, and effective testing is an important part of every coronavirus pandemic safety plan. Testing can potentially be done …Read Story
The latest product releases, company news and microsampling industry updates from Neoteryx.